A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
Clinical trial NCT06468228 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06468228
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-27
- Primary completion
- 2026-12-01
- Enrollment
- 1400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.